Abstract
Background
Asthmatics with aspirin- (ASA) sensitive respiratory disease (ASRD) have a spectrum of respiratory reactions during oral ASA challenge that vary in severity and are temporally associated with leukotriene (LT) formation.Objective
This study investigates the relationship of the severity of ASA-induced respiratory reactions to urinary LTE(4) excretion.Methods
Asthmatics with suspected ASRD underwent oral ASA challenges. Urinary LTE(4) levels were measured at baseline, during the reaction, and after acute ASA desensitization.Results
Asthmatics who had respiratory reactions during oral ASA challenges were divided into 3 groups: asthmatics with naso-ocular reactions and <15% decline from baseline FEV(1) values (group 1), asthmatics with a decline in FEV(1) of 20% to 30% (group 2), and asthmatics with a decline in FEV(1) of >30% (group 3). There were no significant differences in age, baseline FEV(1) values, use of inhaled corticosteroids, daily prednisone doses, prednisone bursts, duration of reactions, or average provoking doses of ASA among the groups. At baseline group 3 asthmatics had significantly higher urinary LTE(4) levels than those in groups 1 or 2. At the time of respiratory reaction to ASA, the urinary LTE(4) levels rose significantly in all groups but were significantly greater among group 3 asthmatics compared with those in groups 1 and 2.Conclusion
The severity of the respiratory reactions during oral ASA challenges was associated with the degree of elevation of baseline LTE(4) synthesis. Our results suggest that asthmatics with ASRD have a spectrum of respiratory tract reactions in which leukotrienes play a distinguishing role.Full text links
Read article at publisher's site: https://doi.org/10.1016/s0091-6749(99)70324-6
Read article for free, from open access legal sources, via Unpaywall: http://www.jacionline.org/article/S0091674999703246/pdf
References
Articles referenced by this article (28)
Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.
Ann Intern Med, (5):975-983 1968
MED: 5646829
Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs
1998
Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration.
J Allergy Clin Immunol, (6):580-587 1983
MED: 6853927
Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin.
J Allergy Clin Immunol, (6):574-579 1983
MED: 6853926
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.
J Allergy Clin Immunol, (5):276-284 1977
MED: 410857
Mechanism of bronchospasm in aspirin-sensitive asthma.
Am Rev Respir Dis, (6 Pt 1):1442-1443 1993
MED: 8256882
Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period.
J Allergy Clin Immunol, (1 Pt 1):11-19 1982
MED: 7054250
Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma.
J Allergy Clin Immunol, (1 Pt 1):59-65 1990
MED: 2299107
Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes.
J Allergy Clin Immunol, (4):751-758 1996
MED: 8876550
Mediator release in an isolated airway segment in subjects with asthma.
Am Rev Respir Dis, (3):641-646 1988
MED: 2449836
Show 10 more references (10 of 28)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/s0091-6749(99)70324-6
Article citations
[Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs (2024, Chengdu)].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 38(6):453-462, 01 Jun 2024
Cited by: 0 articles | PMID: 38858107 | PMCID: PMC11480570
Genomics of Treatable Traits in Asthma.
Genes (Basel), 14(9):1824, 20 Sep 2023
Cited by: 2 articles | PMID: 37761964 | PMCID: PMC10531302
Review Free full text in Europe PMC
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
Clin Sci (Lond), 137(9):727-753, 01 May 2023
Cited by: 11 articles | PMID: 37199256 | PMCID: PMC10195992
Review Free full text in Europe PMC
Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol, 152(3):700-710.e3, 15 Apr 2023
Cited by: 2 articles | PMID: 37068712 | PMCID: PMC10524565
Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis.
Curr Allergy Asthma Rep, 22(12):209-229, 14 Nov 2022
Cited by: 3 articles | PMID: 36374376 | PMCID: PMC9732072
Review Free full text in Europe PMC
Go to all (81) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Funding
Funders who supported this work.
NCRR NIH HHS (1)
Grant ID: M01RR00833
NIAID NIH HHS (1)
Grant ID: K08 AI01394-01
NIDCR NIH HHS (1)
Grant ID: 1-RO1-DE10992